The Biopharma Pod podcast

Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech

0:00
5:10
Spol 15 sekunder tilbage
Spol 15 sekunder frem
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.

Flere episoder fra "The Biopharma Pod"